2018
DOI: 10.1039/c8fo00964c
|View full text |Cite
|
Sign up to set email alerts
|

Resveratrol alleviates motor and cognitive deficits and neuropathology in the A53T α-synuclein mouse model of Parkinson's disease

Abstract: Resveratrol exerts neuroprotective effects on the A53T α-synuclein mouse model of Parkinson's disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
76
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 90 publications
(82 citation statements)
references
References 62 publications
4
76
0
Order By: Relevance
“…Alzheimer's disease protective effects in Aβ1-42-treated PC12 cells via reduction of apoptosis and reduction of oxidative status and mitochondrial damage [51] anti-inflammatory effect via suppression of M1 microglia activation, enhancement of Th2 responses and promotion of anti-inflammatory cytokine and SIRT-1 expression [52] reduction of NF-κB signaling in microglia, which plays a pivotal role in Aβdependent neurodegeneration via SIRT-1 activation [53] Parkinson's disease inhibition of α-synuclein aggregation, reduction of the total α-synuclein and oligomers levels and decrease in cytotoxicity, neuroinflammation and oxidative stress in the A53T α-synuclein mouse model of PD in a dose-dependent manner [54] modulation of the MALAT1/miR-129/SNCA signaling pathway via an increase in TH+ cell number and miR-129 expression and decrease in expression of SNCA and MALAT1 by blocking the transcription of its promoter [55] neuroprotective effect through mitochondria dynamics modulation and upregulation of autophagic flux associated with MEK/extracellular signal-regulated kinase signaling pathway [56] Huntington's disease significant improvement of motor coordination and learning through enhancement of expression of mitochondrial-encoded electron transport chain genes in YAC128 mice, related to increased activation of SIRT-1…”
Section: Condition Effects Of Resveratrol Administration Referencesmentioning
confidence: 99%
“…Alzheimer's disease protective effects in Aβ1-42-treated PC12 cells via reduction of apoptosis and reduction of oxidative status and mitochondrial damage [51] anti-inflammatory effect via suppression of M1 microglia activation, enhancement of Th2 responses and promotion of anti-inflammatory cytokine and SIRT-1 expression [52] reduction of NF-κB signaling in microglia, which plays a pivotal role in Aβdependent neurodegeneration via SIRT-1 activation [53] Parkinson's disease inhibition of α-synuclein aggregation, reduction of the total α-synuclein and oligomers levels and decrease in cytotoxicity, neuroinflammation and oxidative stress in the A53T α-synuclein mouse model of PD in a dose-dependent manner [54] modulation of the MALAT1/miR-129/SNCA signaling pathway via an increase in TH+ cell number and miR-129 expression and decrease in expression of SNCA and MALAT1 by blocking the transcription of its promoter [55] neuroprotective effect through mitochondria dynamics modulation and upregulation of autophagic flux associated with MEK/extracellular signal-regulated kinase signaling pathway [56] Huntington's disease significant improvement of motor coordination and learning through enhancement of expression of mitochondrial-encoded electron transport chain genes in YAC128 mice, related to increased activation of SIRT-1…”
Section: Condition Effects Of Resveratrol Administration Referencesmentioning
confidence: 99%
“…However, increasing cAMP levels via the Epac pathway retards the clearance of autophagy substrates and inhibits α-synuclein clearance, and enhances polyglutamine aggregation in the Parkinson's disease (PD) mouse model [237]. Intriguingly, RSV rescues mutant polyglutamine cytotoxicity [118] and alleviates motor and cognitive deficits in the A53T αsynuclein mouse model of PD [238], whereas SIRTuin inhibition also rescues polyglutamine cytotoxicity [239], and PD [240] and motor deficits after peripheral nerve injury [241]. Similarly, SIRT1 inhibits p53 [242], a known anti-tumor protein, and RSV is known to exert anti-cancer effects through p53 activation [13,243].…”
Section: Rsv Is Also An Indirect Inhibitor Of Sirt1mentioning
confidence: 99%
“…The object recognition test was performed as previously described with some modifications (Lueptow, 2017; Zhang et al, 2018). Briefly, mice were individually habituated to the behavioural arena (50 cm × 50 cm × 25 cm white plastic box, empty) for 5 min 1 day before the test was initiated.…”
Section: Methodsmentioning
confidence: 99%